Preparing "Plan B" For A Mega Study In The Event Of A Supply Issue
Source: Almac Group
What do you do when a “what if” scenario becomes a distinct possibility and has the potential to interrupt your mega-study involving over 10,000 patients in hundreds of sites in various countries around the globe. How do you minimise the risk of treatment interruption, unintentional unblinding, and drug wastage if you must switch modes of drug administration mid-study? For one leading pharmaceutical company, the answer was to rely on Almac Clinical Technology Solutions to provide a contingency plan that could be activated at any moment.
access the Case Study!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.
Subscribe to Clinical Leader
X
Subscribe to Clinical Leader
This website uses cookies to ensure you get the best experience on our website. Learn more